TheEdgeResearch
Home / Stocks / GNNDY

GN Store Nord A/S (GNNDY)

OTC Healthcare Medical - Devices
$46.35 ▲ +0.41%
Market Cap
$2.25B
Sector
Healthcare
Industry
Medical - Devices
Beta
1.53
52-Wk Range
39.45-57.22
CEO
Peter Karlstromer
Country
DK
Currency
USD

GN Store Nord A/S operates in the Medical - Devices industry of the Healthcare sector, headquartered in Ballerup, CR, DK. The stock last traded at $46.35, up 0.41% on the session, giving a market capitalisation of $2.25B. On trailing twelve-month figures it carries a trailing P/E of -39.22, a net margin of -2.5%. Its beta of 1.53 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-39.22
Price / Sales
0.98
Price / Book
1.45
EV / EBITDA
7.14
Gross margin
39.2%
Operating margin
7.5%
Net margin
-2.5%
Return on equity
Debt / equity
0.98
Current ratio
1.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
7,611
IPO date
2013-03-25
Headquarters
Ballerup, CR, DK
About GN Store Nord A/S

GN Store Nord A/S, established in 1869 and headquartered in Ballerup, Denmark, specializes in the creation, manufacturing, and distribution of advanced audio and video communication solutions. These products cater to medical, professional, and consumer sectors across Denmark, the rest of Europe, North America, and various international markets. The company operates through two main divisions: GN Hearing and GN Audio. GN Hearing is dedicated to producing and selling hearing instruments and associated products. In contrast, GN Audio offers a range of professional and consumer products, including headsets, video cameras, and speakerphones. Its portfolio includes well-known brands such as ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy.

Comparable companies

GN Store Nord A/S is most often compared with the following Healthcare names:

ALFRYHAWPYMCRPFOSSFFOSSUYSTSEYTCGGYTCHBFVRBCFVTRLY
More research on GNNDY
GNNDY technical analysis GNNDY TheEdge Score Compare against peers
Open full interactive analysis & DCF →